PolyPid Ltd. (PYPD) Stock Ticker
PYPD right now
Market factors today
Unlock the full PYPD picture
About PolyPid Ltd.
PolyPid Ltd. is an advanced-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of therapeutic solutions. These solutions are based on its proprietary polymer-lipid encapsulation matrix (PLEX) platform, with the goal of addressing significant unmet medical needs. The company's leading product candidate, D-PLEX100, is currently undergoing Phase III clinical trials. It is being evaluated for its efficacy in preventing surgical site infections (SSIs) following both sternal (bone) and abdominal (soft tissue) procedures. Established in 2008, PolyPid Ltd. is headquartered in Petah Tikva, Israel.
PYPD stock facts
| Ticker symbol | PYPD |
| Exchange | NASDAQ Global Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $99.6M |
| CEO | Dikla Czaczkes Akselbrad |
| Employees | 72 |
| Headquarters | Petah Tikva, HM, IL |
| IPO date | 2020-06-26 |
| Website | www.polypid.com |
What you can see for PYPD on Tickr
Live PYPD price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the PYPD report.
Rankings
FAQ
What is the ticker symbol for PolyPid Ltd.?
The ticker symbol for PolyPid Ltd. is PYPD, listed on the NASDAQ Global Market.
What is PYPD?
PolyPid Ltd. is an advanced-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of therapeutic solutions. These solutions are based on its proprietary polymer-lipid encapsulation matrix (PLEX) platform, with the goal of addressing significant unmet medical needs. The company's leading product candidate, D-PLEX100, is currently undergoing Phase…